- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Primedex to explore strategic options
California imaging services provider Primedex announced last monththat it is exploring new options for the company, including possiblepartnerships or alliances. The announcement came as no great surprise, given recent Primedexhistory and the general
California imaging services provider Primedex announced last monththat it is exploring new options for the company, including possiblepartnerships or alliances.
The announcement came as no great surprise, given recent Primedexhistory and the general popularity of mergers and acquisitionsin the imaging service sector. Primedex nearly acquired San Diego'sMedical Imaging Centers of America in July, only to lose out toan 11th-hour bid by U.S. Diagnostic Labs. USDL has a deal pendingto acquire MICA's 17 centers for about $32 million (SCAN 7/31/96).
A merger in May with Diagnostic Imaging Services brought 10Southern California imaging centers, 15 ultrasound labs, and 13mobile ultrasound units into the Primedex fold. Before that deal,Los Angeles-based Primedex operated 19 California imaging centersthrough its RadNet subsidiary. Its Future Diagnostics subsidiaryarranges brokered imaging services for 180 imaging centers inthe state.
In a statement, Primedex president and CEO Dr. Howard Bergersaid that his company's board of directors had determined thatthe time is right to explore alternatives to enhance the company'svalue and position. He declined to elaborate on the announcementwhen contacted by SCAN.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
